Latest Articles

Publication Date
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival - Bioengineer.org

Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival Bioengineer.org

Published: Oct. 14, 2025, 5:14 p.m.
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival - BIOENGINEER.ORG

Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival BIOENGINEER.ORG

Published: Oct. 14, 2025, 5:14 p.m.
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival - bioengineer.org

Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival bioengineer.org

Published: Oct. 14, 2025, 5:14 p.m.
“We’ve spent $100k on fertility treatment and still don’t have a baby” - MSN

“We’ve spent $100k on fertility treatment and still don’t have a baby” MSN

Published: Oct. 14, 2025, 5:13 p.m.
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - Bioengineer.org

Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival Bioengineer.org

Published: Oct. 14, 2025, 4:49 p.m.
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - BIOENGINEER.ORG

Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival BIOENGINEER.ORG

Published: Oct. 14, 2025, 4:49 p.m.
Integrating homologous recombination deficiency subtyping with TCGA molecular classification for enhanced prognostic stratification and personalised therapy in endometrial cancer - Nature

Integrating homologous recombination deficiency subtyping with TCGA molecular classification for enhanced prognostic stratification and personalised therapy in endometrial cancer Nature

Published: Oct. 14, 2025, 4:47 p.m.
Why Jennifer Aniston Never Wanted to Adopt Kids - E! News

Why Jennifer Aniston Never Wanted to Adopt Kids E! News

Published: Oct. 14, 2025, 2:58 p.m.
The Traitors' Elen Wyn reveals she has two wombs and cervixes amid endometriosis battle - The Mirror

The Traitors' Elen Wyn reveals she has two wombs and cervixes amid endometriosis battle The Mirror

Published: Oct. 14, 2025, 2:52 p.m.
Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials - BMC Cancer

Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials BMC Cancer

Published: Oct. 14, 2025, 2:41 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!